Latest Financial Guidance News

Austin Engineering has lowered its FY26 revenue and EBIT forecasts due to challenges in key contracts and operational inefficiencies, while outlining strategic measures to restore profitability.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

McPherson’s Limited updates shareholders on its ongoing transformation journey, reporting modest core brand growth in FY25 and outlining a strategic outlook for FY26 focused on sustainable expansion and operational efficiency.

James Hardie confirms key board changes and underscores its commitment to shareholder value amid strong integration progress with AZEK.

Centuria Office REIT reported its strongest quarterly leasing performance to date, signing over 23,400 sqm across key properties while maintaining solid occupancy and reaffirming its FY26 financial guidance.

Credit Corp Group has reaffirmed its FY26 guidance, highlighting robust earnings growth driven by operational improvements across its US debt buying and Australian/New Zealand lending segments.

Insurance Australia Group (IAG) has upgraded its FY26 financial guidance following the acquisition of RACQ’s insurance business, projecting stronger premium growth and higher profits.

Eden Innovations reports a surge in US orders and quotations for its OptiBlend dual fuel kits, driven by growing demand from data centres. Recent sales exceed US$300k, with a robust pipeline of US$4.4 million signalling strong market momentum.

Adairs Limited has updated its first half FY26 sales and gross margin guidance, reflecting moderated growth and mixed brand performances as it prepares for a critical peak trading period.

Air New Zealand has revised its first half 2026 financial outlook to a pre-tax loss between NZD 30 million and 55 million, citing weaker revenue growth and rising costs. The airline is pushing cost-saving measures while highlighting uncertainties ahead.

Findi Limited updates FY26 guidance with over A$100 million revenue forecast, announces acquisition of Sphere loyalty platform, and advances IPO plans on Bombay Stock Exchange.

AVITA Medical has appointed Board Chairman Cary Vance as Interim CEO following Jim Corbett's departure, while preliminary third-quarter revenue is expected to reach approximately $17 million.